Valeant, Ackman Make Allergan Bid

Activist investor William Ackman and Valeant Pharmaceuticals revealed their offer to acquire Allergan, valuing the Botox maker at about $46 billion.

Leave a Reply

Your email address will not be published. Required fields are marked *